{"id":535569,"date":"2021-09-08T08:33:18","date_gmt":"2021-09-08T12:33:18","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/brickell-biotech-to-participate-at-upcoming-september-conferences\/"},"modified":"2021-09-08T08:33:18","modified_gmt":"2021-09-08T12:33:18","slug":"brickell-biotech-to-participate-at-upcoming-september-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/brickell-biotech-to-participate-at-upcoming-september-conferences\/","title":{"rendered":"Brickell Biotech to Participate at Upcoming September Conferences"},"content":{"rendered":"
\n

BOULDER, Colo., Sept. 08, 2021 (GLOBE NEWSWIRE) — Brickell Biotech, Inc. (\u201cBrickell\u201d) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of dermatologic, autoimmune and other debilitating diseases, today announced that it is scheduled to participate in two upcoming virtual investment conferences, including the H.C. Wainwright 23rd<\/sup> Annual Global Investment Conference, taking place September 13 \u2013 15, and the Lake Street Partners 5th<\/sup> Annual Best Ideas Growth Conference, taking place September 14 \u2013 15.<\/p>\n

\n
\n Conference Details<\/u>
\n <\/strong>\n <\/p>\n\n\n\n\n\n\n\n\n\n\n
Conference:<\/td>\n\n H.C. Wainwright 23<\/em>
\n
\n rd <\/em>
\n <\/sup>
\n Annual Global Investment Conference<\/em>\n <\/td>\n<\/tr>\n
Presenter:<\/td>\nRobert Brown, Brickell\u2019s Chief Executive Officer<\/td>\n<\/tr>\n
Presentation Date and Time:<\/td>\nThe presentation will be available starting at 7:00 a.m. ET on Monday, September 13th<\/sup><\/td>\n<\/tr>\n
Webcast:<\/td>\n\n Click here for webcast link<\/a>\n <\/td>\n<\/tr>\n
Meetings:<\/td>\nManagement will be available for virtual 1-on-1 meetings on September 13th<\/sup>, 14th<\/sup>, and 15th<\/sup>. If you are interested in scheduling a 1-on-1, please contact your H.C. Wainwright representative.<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
Conference:<\/td>\n\n Lake Street Capital Partners 5<\/em>
\n
\n th<\/em>
\n <\/sup>
\n Annual Best Ideas Growth Conference<\/em>\n <\/td>\n<\/tr>\n
Meetings:<\/td>\nManagement will be available for virtual 1-on-1 meetings on September 14th<\/sup> and 15th<\/sup>. If you are interested in scheduling a 1-on-1, please contact your Lake Street Capital representative.<\/td>\n<\/tr>\n
Note:<\/td>\nPlease note that a presentation is not being provided as part of this event.<\/td>\n<\/tr>\n<\/table>\n

\n About Brickell<\/strong>
\n \n <\/p>\n

Brickell Biotech, Inc. is a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of dermatologic, autoimmune and other debilitating diseases. Brickell\u2019s pipeline combines a potential best-in-class, late clinical-stage program for hyperhidrosis with a novel, cutting-edge platform and development stage candidates with broad potential in autoimmune and neuroinflammatory disorders. Brickell\u2019s executive management team and board of directors bring extensive experience in product development and global commercialization, having served in leadership roles at large global pharmaceutical companies and biotechs that have developed and\/or launched successful products, including several that were first-in-class and\/or achieved iconic status, such as Cialis\u00ae<\/sup>, Taltz\u00ae<\/sup>, Gemzar\u00ae<\/sup>, Prozac\u00ae<\/sup>, Cymbalta\u00ae<\/sup> and Juvederm\u00ae<\/sup>. Brickell\u2019s strategy is to leverage this experience to in-license, acquire, develop and commercialize innovative and differentiated pharmaceutical products that Brickell believes can meaningfully benefit patients who are suffering from chronic debilitating diseases that are underserved by available therapies. For more information, visit\u00a0https:\/\/www.brickellbio.com<\/a>.<\/p>\n

\n Brickell Investor Contact:<\/strong><\/p>\n

Dan Ferry
LifeSci Advisors
(617) 430-7576
daniel@lifesciadvisors.com<\/a><\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

BOULDER, Colo., Sept. 08, 2021 (GLOBE NEWSWIRE) — Brickell Biotech, Inc. (\u201cBrickell\u201d) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of dermatologic, autoimmune and other debilitating diseases, today announced that it is scheduled to participate in two upcoming virtual investment conferences, including the H.C. Wainwright 23rd Annual Global Investment Conference, taking place September 13 \u2013 15, and the Lake Street Partners 5th Annual Best Ideas Growth Conference, taking place September 14 \u2013 15. Conference Details Conference: H.C. Wainwright 23 rd Annual Global Investment Conference Presenter: Robert Brown, Brickell\u2019s Chief Executive Officer Presentation Date and Time: The presentation will be available starting at 7:00 a.m. ET on Monday, … <\/p>\n

Continue reading “Brickell Biotech to Participate at Upcoming September Conferences”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-535569","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBrickell Biotech to Participate at Upcoming September Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/brickell-biotech-to-participate-at-upcoming-september-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Brickell Biotech to Participate at Upcoming September Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOULDER, Colo., Sept. 08, 2021 (GLOBE NEWSWIRE) — Brickell Biotech, Inc. (\u201cBrickell\u201d) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of dermatologic, autoimmune and other debilitating diseases, today announced that it is scheduled to participate in two upcoming virtual investment conferences, including the H.C. Wainwright 23rd Annual Global Investment Conference, taking place September 13 \u2013 15, and the Lake Street Partners 5th Annual Best Ideas Growth Conference, taking place September 14 \u2013 15. Conference Details Conference: H.C. Wainwright 23 rd Annual Global Investment Conference Presenter: Robert Brown, Brickell\u2019s Chief Executive Officer Presentation Date and Time: The presentation will be available starting at 7:00 a.m. ET on Monday, … Continue reading "Brickell Biotech to Participate at Upcoming September Conferences"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/brickell-biotech-to-participate-at-upcoming-september-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-08T12:33:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTg4MiM0MzkzOTUyIzIxODkwNDQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brickell-biotech-to-participate-at-upcoming-september-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brickell-biotech-to-participate-at-upcoming-september-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Brickell Biotech to Participate at Upcoming September Conferences\",\"datePublished\":\"2021-09-08T12:33:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brickell-biotech-to-participate-at-upcoming-september-conferences\\\/\"},\"wordCount\":390,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brickell-biotech-to-participate-at-upcoming-september-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMTg4MiM0MzkzOTUyIzIxODkwNDQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brickell-biotech-to-participate-at-upcoming-september-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brickell-biotech-to-participate-at-upcoming-september-conferences\\\/\",\"name\":\"Brickell Biotech to Participate at Upcoming September Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brickell-biotech-to-participate-at-upcoming-september-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brickell-biotech-to-participate-at-upcoming-september-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMTg4MiM0MzkzOTUyIzIxODkwNDQ=\",\"datePublished\":\"2021-09-08T12:33:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brickell-biotech-to-participate-at-upcoming-september-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brickell-biotech-to-participate-at-upcoming-september-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brickell-biotech-to-participate-at-upcoming-september-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMTg4MiM0MzkzOTUyIzIxODkwNDQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMTg4MiM0MzkzOTUyIzIxODkwNDQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brickell-biotech-to-participate-at-upcoming-september-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Brickell Biotech to Participate at Upcoming September Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Brickell Biotech to Participate at Upcoming September Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/brickell-biotech-to-participate-at-upcoming-september-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Brickell Biotech to Participate at Upcoming September Conferences - Market Newsdesk","og_description":"BOULDER, Colo., Sept. 08, 2021 (GLOBE NEWSWIRE) — Brickell Biotech, Inc. (\u201cBrickell\u201d) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of dermatologic, autoimmune and other debilitating diseases, today announced that it is scheduled to participate in two upcoming virtual investment conferences, including the H.C. Wainwright 23rd Annual Global Investment Conference, taking place September 13 \u2013 15, and the Lake Street Partners 5th Annual Best Ideas Growth Conference, taking place September 14 \u2013 15. Conference Details Conference: H.C. Wainwright 23 rd Annual Global Investment Conference Presenter: Robert Brown, Brickell\u2019s Chief Executive Officer Presentation Date and Time: The presentation will be available starting at 7:00 a.m. ET on Monday, … Continue reading \"Brickell Biotech to Participate at Upcoming September Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/brickell-biotech-to-participate-at-upcoming-september-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-08T12:33:18+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTg4MiM0MzkzOTUyIzIxODkwNDQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brickell-biotech-to-participate-at-upcoming-september-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brickell-biotech-to-participate-at-upcoming-september-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Brickell Biotech to Participate at Upcoming September Conferences","datePublished":"2021-09-08T12:33:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brickell-biotech-to-participate-at-upcoming-september-conferences\/"},"wordCount":390,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brickell-biotech-to-participate-at-upcoming-september-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTg4MiM0MzkzOTUyIzIxODkwNDQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brickell-biotech-to-participate-at-upcoming-september-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/brickell-biotech-to-participate-at-upcoming-september-conferences\/","name":"Brickell Biotech to Participate at Upcoming September Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brickell-biotech-to-participate-at-upcoming-september-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brickell-biotech-to-participate-at-upcoming-september-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTg4MiM0MzkzOTUyIzIxODkwNDQ=","datePublished":"2021-09-08T12:33:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brickell-biotech-to-participate-at-upcoming-september-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/brickell-biotech-to-participate-at-upcoming-september-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brickell-biotech-to-participate-at-upcoming-september-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTg4MiM0MzkzOTUyIzIxODkwNDQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTg4MiM0MzkzOTUyIzIxODkwNDQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brickell-biotech-to-participate-at-upcoming-september-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Brickell Biotech to Participate at Upcoming September Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/535569","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=535569"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/535569\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=535569"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=535569"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=535569"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}